Theseus Pharmaceuticals, Inc.
Theseus Pharmaceuticals, Inc.（THRX）股票概览
关键指标与盈利、估值、营收、股息等标签页深链。
FMP · THRX · 截至 Jun 9, 2026
关键指标
探索 Theseus Pharmaceuticals, Inc. 数据
thrx stock data · financials财务快照
完整财报分析师评级与目标价
完整预测合计: 12 · 买入占比: 66.7%
竞争对手与同行
thrx competitorsTHRX
ATYR
CRGX
FSTX
LENZ
LSB股票表现
完整历史关于 Theseus Pharmaceuticals, Inc.
Theseus Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing, and bringing to market targeted treatments for cancer patients. Their leading investigational compound,…
what is theseus pharmaceuticals, inc. · thrx stock overview · theseus pharmaceuticals, inc. company profile · who is theseus pharmaceuticals, inc. ceo · thrx NASDAQ · theseus pharmaceuticals, inc. headquarters · theseus pharmaceuticals, inc. business segments
关于股票概览与关键数据
Theseus Pharmaceuticals, Inc.（THRX）是 Biotechnology 行业的 Healthcare 类公司，于 Oct 7, 2021 在 NASDAQ 上市。截至最近交易日，THRX 股价为 $4.07，市值约为 $181.5M。过去12个月累计回报 -47.95%，年初至今回报 +1.63%。
根据 12 位华尔街分析师，Theseus Pharmaceuticals, Inc. 股票共识评级为Buy，12个月平均目标价为 $—。2022 财年 Theseus Pharmaceuticals, Inc. 营收 —，净利润 -$47.1M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。
常见问题
截至最近一个交易日，Theseus Pharmaceuticals, Inc.（THRX）股价为 $4.07，在 NASDAQ 上市，52周区间为 $2.05 – $12.37。